Coleman Mark's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Jun 2, 2026
- Accession no.
- 0001193125-26-254038
- Filed
- Jun 2, 2026
- Trade date
- May 29-Jun 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $4.02M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coleman MarkCIK 0001658379 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | SSaleDisposed | −6,000 | $233.46F3 | −$1,400,760 | 41,140 | Direct | |
| Jun 1, 2026 | Common Stock | SSaleDisposed | −6,000 | $230.30F4 | −$1,381,800 | 35,140 | Direct | |
| Jun 2, 2026 | Common Stock | SSaleDisposed | −5,537 | $223.39F5 | −$1,236,910.43 | 29,603 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $231.50 and $235.23.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $229.56 and $232.14.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $221.82 and $225.21.
Referenced by the price of 1 transaction in Table I.